Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281515
Status:
COMPLETED
Last Update Posted:
2012-06-29
First Post:
2006-01-24
Brief Title:
Comparison of PaclitaxelCarboplatin and Lonafarnib to PaclitaxelCarboplatin for First-line Treatment of Ovarian Cancer
Sponsor:
AGO Study Group
Organization:
AGO Study Group
Organization Data
Organization:
AGO Study Group
Class:
OTHER
Study ID:
AGO-OVAR 15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AGO Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None